Description

6,7-Dichloro-2-Methyl-3-(Trifluoromethyl)Quinoxaline is a high-value, multi-functional heterocyclic building block characterized by its halogenated and trifluoromethyl-substituted quinoxaline core. This compound is specifically engineered to serve as a critical synthetic intermediate in the development of advanced materials and active pharmaceutical ingredients (APIs). It is primarily sought after by research and development teams in the pharmaceutical, agrochemical, and specialty chemical industries for constructing complex molecular architectures.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, and anti-infective therapies.
• Agrochemical Synthesis: Used in the research and production of next-generation herbicides, fungicides, and insecticides, leveraging its halogenated structure for enhanced bioactivity.
• Organic Electronic Materials: Serves as a building block for electron-deficient units in the development of organic semiconductors, OLEDs, and photovoltaic materials.
• Ligand and Catalyst Development: Employed in the creation of specialized ligands for transition metal catalysis and in organometallic chemistry research.
• Fluorinated Compound Research: The trifluoromethyl group makes it a valuable scaffold for studying structure-activity relationships (SAR) in medicinal and material chemistry.
• Custom Synthesis and Contract Manufacturing: Supplied to CDMOs and research institutions for bespoke synthesis projects requiring high-purity, complex heterocycles.

Basic Information

Product Name	6,7-Dichloro-2-Methyl-3-(Trifluoromethyl)Quinoxaline
CAS No.	143309-87-9
Molecular Formula	C11H5Cl2F3N2
Molecular Weight	305.07 g/mol
Synonyms	2-Methyl-6,7-dichloro-3-(trifluoromethyl)quinoxaline; 6,7-Dichloro-2-methyl-3-trifluoromethylquinoxaline; Quinoxaline, 6,7-dichloro-2-methyl-3-(trifluoromethyl)-; 3-(Trifluoromethyl)-6,7-dichloro-2-methylquinoxaline
EINECS	Contact for details

Quality Control

Our production of 6,7-Dichloro-2-Methyl-3-(Trifluoromethyl)Quinoxaline adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot is analyzed using advanced techniques including HPLC, GC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with every shipment to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at room temperature (15-25°C). Keep away from strong acids, strong bases, and strong oxidizing agents. The container should be kept tightly sealed to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC/IR)	Conforms to standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.